Last reviewed · How we verify

NCT06313866

the Clinical Effect of TCM Sniffing Therapy Combined With Electroacupuncture in PSCI

Recruiting now NA Last updated 20 February 2025
What this trial tests

NA trial testing control in Stroke in 220 participants. Currently enrolling.

Timeline
1 April 2024
Primary endpoint
1 April 2025
1 June 2025

Quick facts

Lead sponsorHangzhou Medical College
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment220
Start date1 April 2024
Primary completion1 April 2025
Estimated completion1 June 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Hangzhou Medical College

Who can join

Under 70, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The patients with cognitive impairment after stroke were divided into control group, electroacupuncture group, olfactory therapy group, electroacupuncture combined with olfactory therapy group, and sham group with 35 people in each group. After the end of the treatment, the clinical efficacy was evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Therapeutic Effects of Acorus Tatarinowii Volatile Oil and Electroacupuncture in Post-Stroke Cognitive Impairment Patients: A Clinical Trial Protocol.
    Dandan Y, Jingting Z, Minzhe W, Zhuoyue C, et al · · 2025 · PMID 40607608 · DOI 10.1002/brb3.70631

Verify or expand the search:

Other trials of control

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hangzhou Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06313866.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing